Skip to main content

Tidal Investments LLC

Source: SEC Form 13F · as of Mar 2026

Tidal Investments LLC holds 63 biotech & pharma companies tracked by BioSniper, totaling $282.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

63

Total value held

$282.4M

BioSniper AIPage context preserved

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.501,840$69.2M
REGNREGENERON PHARMACEUTICALS, INC.39,652$30.2M
ALNYALNYLAM PHARMACEUTICALS, INC.57,927$18.8M
EXELEXELIXIS, INC.382,343$16.4M
RVMDREVOLUTION MEDICINES, INC.137,242$13.2M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)210,633$11.5M
INSMINSMED Inc61,776$9.7M
BBIOBridgeBio Pharma, Inc.129,601$9.5M
COGTCogent Biosciences, Inc.231,569$8.9M
GRFSGrifols S.A.1,123,470$8.5M
INCYIncyte Corp.77,066$7.1M
SNYSanofi136,006$6.4M
NUVLNuvalent, Inc.53,415$5.5M
GMABGenmab A/S184,124$4.9M
MRNAModerna, Inc.97,031$4.8M
ONCBeOne Medicines Ltd.12,633$3.8M
JAZZJazz Pharmaceuticals plc19,413$3.6M
ARWRARROWHEAD PHARMACEUTICALS, INC.47,830$3.0M
TEVATeva Pharmaceutical Industries Limited99,173$3.0M
BMRNBIOMARIN PHARMACEUTICAL INC48,445$2.7M
ZYMEZymeworks Inc.104,931$2.6M
IONSIONIS PHARMACEUTICALS INC34,432$2.5M
ROIVRoivant Sciences Ltd.88,735$2.3M
SMMTSummit Therapeutics Inc.120,314$2.3M
ANABANAPTYSBIO, INC36,352$2.0M
RCUSArcus Biosciences, Inc.86,342$1.9M
ELVNEnliven Therapeutics, Inc.47,515$1.9M
NUVBNuvation Bio Inc.392,754$1.7M
IMTXImmatics N.V.170,389$1.7M
RLAYRelay Therapeutics, Inc.154,100$1.5M
OGNOrganon & Co.241,412$1.4M
CYTKCYTOKINETICS INC19,983$1.3M
VKTXViking Therapeutics, Inc.39,554$1.3M
OLMAOlema Pharmaceuticals, Inc.85,151$1.3M
PTGXProtagonist Therapeutics, Inc11,034$1.2M
CTMXCytomX Therapeutics, Inc.245,768$1.2M
HCMHUTCHMED (China) Limited67,385$1.0M
IMCRImmunocore Holdings plc30,651$924K
CGEMCullinan Therapeutics, Inc.62,421$887K
ARVNARVINAS, INC.83,581$886K
ARGXARGENX SE1,194$846K
FOLDAMICUS THERAPEUTICS, INC.52,382$757K
BBOTBridgeBio Oncology Therapeutics, Inc.82,172$735K
CMPXCompass Therapeutics, Inc.138,276$731K
ORICOric Pharmaceuticals, Inc.57,602$730K
NAMSNEWAMSTERDAM PHARMA CO N.V.22,458$719K
DAWNDay One Biopharmaceuticals, Inc.32,074$688K
IOVAIOVANCE BIOTHERAPEUTICS, INC.184,115$646K
AXSMAxsome Therapeutics, Inc.3,685$623K
AGIOAGIOS PHARMACEUTICALS, INC.14,376$486K
SRRKScholar Rock Holding Corp9,791$481K
INVAInnoviva, Inc.18,253$425K
SLSSELLAS Life Sciences Group, Inc.90,007$381K
ORKAOruka Therapeutics, Inc.6,546$321K
KNSAKiniksa Pharmaceuticals International, plc6,184$298K
STOKStoke Therapeutics, Inc.8,540$278K
LQDALiquidia Corp6,859$259K
GPCRStructure Therapeutics Inc.4,643$224K
NTLAIntellia Therapeutics, Inc.14,076$180K
DRTSAlpha Tau Medical Ltd.25,093$177K
RDYDR REDDYS LABORATORIES LTD10,272$142K
XERSXeris Biopharma Holdings, Inc.18,159$105K
ATAIAtai Beckley N.V.15,574$55K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.